Bildkälla: Stockfoto

Carasent Q3’23: Initial comment - Redeye

Redeye comments on Carasent's Q3 2023 report, which was heavily influenced by lower consulting revenue and seasonality effects related to the summer months, which we underestimated. The ARR was flattish q/q and churn remained low (about 2%). The EBITDA - CAPEX margin continued to strengthen q/q as well, although it was still in the negative (as expected).

Redeye comments on Carasent's Q3 2023 report, which was heavily influenced by lower consulting revenue and seasonality effects related to the summer months, which we underestimated. The ARR was flattish q/q and churn remained low (about 2%). The EBITDA - CAPEX margin continued to strengthen q/q as well, although it was still in the negative (as expected).
Börsvärldens nyhetsbrev
ANNONSER